USOR 24004 - STAR Ph3 study to evaluate to treat patients with HNSCC

A phase 3 open-label, randomized, controlled study to evaluate the efficacy and safety of petosemtamab compared with investigator's choice monotherapy treatment in previously treated patients with incurable, metastatic/recurrent head and neck squamous cell carcinoma (MCLA-158-CL02)

Disease Types: Head/Neck, STAR: Selected Trials Available for Accelerated Four Week Rollout

Available at: Arlington Heights, Niles